Molecule Details
InChIKeyZEUITGRIYCTCEM-KRWDZBQOSA-N
Compound NameDuloxetine
Canonical SMILESCNCC[C@H](Oc1cccc2ccccc12)c1cccs1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)12
Pfam Stratification Cross-Family
Avg pChEMBL6.49
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00476
Drug NameDuloxetine
CAS Number116539-59-4
Groups approved investigational
ATC Codes N06AX21
DescriptionDuloxetine is a dual serotonin and norepinephrine reuptake inhibitor.[label] It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686.[A178741] Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder.[L...

Categories: Agents producing tachycardia Analgesics Antidepressive Agents Antidepressive Agents Indicated for Depression Central Nervous System Agents Central Nervous System Depressants Combined Inhibitors of Serotonin/Norepinephrine Reuptake Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP2B6 Inhibitors Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) Cytochrome P-450 CYP2C19 Inhibitors Cytochrome P-450 CYP2C19 inhibitors (strength unknown) Cytochrome P-450 CYP2C9 Substrates Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (moderate) Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Inhibitors (weak) Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Hypoglycemia-Associated Agents Membrane Transport Modulators Nervous System Neurotransmitter Uptake Inhibitors Norepinephrine Uptake Inhibitors P-glycoprotein inhibitors Peripheral Nervous System Agents Psychoanaleptics Psychotropic Drugs Selective Serotonin Reuptake Inhibitors Sensory System Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin Agents Serotonin Modulators Serotonin and Noradrenaline Reuptake Inhibitors Sulfur Compounds Thiophenes
Cross-references: BindingDB: 84745 ChEBI: 36795 CHEMBL1175 ChemSpider: 54822 Drugs Product Database (DPD): 20171 Guide to Pharmacology: 202 IUPHAR: 202 PDB: 29E PharmGKB: PA10066 PubChem:60835 PubChem:46507937 RxCUI: 72625 Therapeutic Targets Database: DAP000494 Wikipedia: Duloxetine ZINC: ZINC000001536779
Target Activities (12)
Target Gene Organism Category Pfam pChEMBL Type Source
P31645 SLC6A4 Homo sapiens Human PF03491 PF00209 8.4 IC50 ChEMBL;BindingDB
P23975 SLC6A2 Homo sapiens Human PF00209 8.1 IC50 ChEMBL;BindingDB
P50406 HTR6 Homo sapiens Human PF00001 6.4 Ki BindingDB
P08684 CYP3A4 Homo sapiens Human PF00067 6.4 IC50 ChEMBL;BindingDB
Q01959 SLC6A3 Homo sapiens Human PF00209 6.4 Ki ChEMBL;BindingDB
P28223 HTR2A Homo sapiens Human PF00001 6.3 Ki BindingDB
P28335 HTR2C Homo sapiens Human PF00001 6.0 Ki BindingDB
P08172 CHRM2 Homo sapiens Human PF00001 6.0 Ki BindingDB
P08913 ADRA2A Homo sapiens Human PF00001 6.0 Ki BindingDB
P10635 CYP2D6 Homo sapiens Human PF00067 6.0 IC50 ChEMBL;BindingDB
P11229 CHRM1 Homo sapiens Human PF00001 6.0 Ki BindingDB
P25929 NPY1R Homo sapiens Human PF00001 6.0 Ki BindingDB
DrugBank Target Actions (14)
Target Gene Target Name Action Type
P02763 P02763 alpha1-acid glycoprotein ligand carriers
P02768 ALB Albumin ligand carriers
P05177 CYP1A2 Cytochrome P450 1A2 inhibitor enzymes
P08684 CYP3A4 Cytochrome P450 3A4 inhibitor enzymes
P10635 CYP2D6 Cytochrome P450 2D6 inhibitor enzymes
P20813 CYP2B6 Cytochrome P450 2B6 inhibitor enzymes
P33261 CYP2C19 Cytochrome P450 2C19 inhibitor enzymes
P05177 CYP1A2 Cytochrome P450 1A2 substrate enzymes
P10635 CYP2D6 Cytochrome P450 2D6 substrate enzymes
P11712 CYP2C9 Cytochrome P450 2C9 substrate enzymes
P23975 SLC6A2 Sodium-dependent noradrenaline transporter inhibitor targets
P31645 SLC6A4 Sodium-dependent serotonin transporter inhibitor targets
Q01959 SLC6A3 Sodium-dependent dopamine transporter inhibitor targets
P08183 ABCB1 ATP-dependent translocase ABCB1 inhibitor transporters